The Board of Directors of the Romanian pharmaceutical manufacturer Biofarm (BVB: BIO) officially approved the public takeover bid launched by the Polish group Zakłady Farmaceutyczne Polpharma on Monday, May 25. The company leadership adopted a resolution approving the offer announced by Polpharma on May 20. The offer targets the acquisition of 985.3 million ordinary shares, representing 100% of the company’s share capital.